A number needed to screen and cost-effectiveness analysis of the SOMIT-data.
Otten
H M
HM
Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands. j.m.otten@amc.uva.nl
Prins
M H
MH
D003362:Cost-Benefit Analysis / Q000379:methods; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000191:economics*; D009716:Numerical Analysis, Computer-Assisted; D013923:Thromboembolism / Q000150:complications*; D020246:Venous Thrombosis / Q000150:complications*